Press Releases
Saluda Medical Receives Regulatory Approval for EVA™ Sensing Technology in Europe with recognition in Australia
Minneapolis, United States
January 8, 2026
Read More
Saluda Medical Announces Full U.S. Launch of EVA™ Sensing Technology for Use with the Evoke® SmartLoop™ System
Minneapolis, United States
July 17, 2025
Read More
Saluda Medical Appoints Barry Regan as Chief Executive Officer
Minneapolis, United States
June 30, 2025
Follows the Addition of Mike Mathias as Chief Commercial Officer in Late 2024 and Jim Erickson as Chief Financial Officer in Late 2023
Read More
Saluda Medical Announces Presentation of New Clinical Data at the 2025 NANS Annual Meeting
Minneapolis, United States
February 7, 2025
Read More
Saluda Medical Receives FDA Approval for First Automated Programming Platform in SCS
Minneapolis, United States
February 5, 2025
Read More
Saluda Medical Announces Closing of $100 Million Financing
Minneapolis, United States
January 17, 2025
Read More
For more information, please contact:
Media and Investor Contact:
Brian Johnston
Gilmartin Group
(332) 895-3222
brian@gilmartinir.com